Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Beyond the Gates is teaming up with the Know Your Lemons Foundation to raise awareness about very important health ...

For Chase Johnson, an unexpected change in her dog’s behavior became a life-altering warning. At 31, Johnson noticed her ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Beyond the Gates is doing important work in raising awareness about breast cancer through a storyline that will resonate with ...

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.

Pitavastatin, a cholesterol lowering drug, slashes chemotherapy resistance in breast cancer by obstructing a specific protein ...

At Thomas’s first oncology appointment, her doctor told her to prepare for the worst. “[It] was absolutely soul crushing,” says Thomas. She immediately searched for other women with triple-negative ...

By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative breast cancer, the most aggressive and difficult to treat subtype of the ...